TY - JOUR
KW - Buprenorphine/therapeutic use
KW - COVID-19/epidemiology/prevention & control
KW - Drug Prescriptions
KW - Health Policy/legislation & jurisprudence
KW - Health Services Accessibility/legislation & jurisprudence
KW - Humans
KW - Legislation, Drug
KW - Narcotic Antagonists/therapeutic use
KW - Nurse Practitioners/legislation & jurisprudence
KW - opioid epidemic
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Physician Assistants/legislation & jurisprudence
KW - Physicians/legislation & jurisprudence
KW - SARS-CoV-2
KW - Telemedicine
KW - United States/epidemiology
AU - M. Mitchell
AU - K. Shee
AU - K. Champlin
AU - A. C. Essary
AU - M. Evans
A1 - 
AD - Michaela Mitchell and Kameron Shee are research interns at HonorHealth Academic Affairs in Scottsdale, Ariz. Kelly Champlin is a medical student in Midwestern University's Arizona College of Osteopathic Medicine. Alison C. Essary is Scrivner Family Director of the Research, Quality Improvement, and Patient Safety program at HonorHealth Academic Affairs, and an adjunct clinical professor in the College of Health Sciences at Northern Arizona University's Phoenix Biomedical Campus. Matthew Evans is a fellow in addiction medicine at HonorHealth/Community Bridges, Inc. The authors have disclosed no potential conflicts of interest, financial or otherwise.
BT - JAAPA : official journal of the American Academy of Physician Assistants
C5 - Education & Workforce; Opioids & Substance Use
CP - 6
CY - United States
DO - 10.1097/01.JAA.0000742976.14811.36
IS - 6
JF - JAAPA : official journal of the American Academy of Physician Assistants
LA - eng
M1 - Journal Article
PB - American Academy of Physician Assistants
PP - United States
PY - 2021
SN - 1547-1896; 0893-7400
SP - 1
EP - 4
EP - 
T1 - Opioid use disorder and COVID-19: Implications for policy and practice
T2 - JAAPA : official journal of the American Academy of Physician Assistants
TI - Opioid use disorder and COVID-19: Implications for policy and practice
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34031321
U3 - 10.1097/01.JAA.0000742976.14811.36
VL - 34
VO - 1547-1896; 0893-7400
Y1 - 2021
Y2 - Jun 1
ER -